The approval of a Food and Drug Administration (FDA) emergency use authorization (EUA) for AstraZeneca’s COVID-19 vaccine AZD1222 will boost confidence and use of the vaccine globally. Such an approval will also motivate uptake in countries within vaccine alliance Gavi, says GlobalData, a leading data